Virological Profile of Patients Infected with HIV Starting Antiretroviral Treatment in Kinshasa

Open Access Library Journal

ISSN Print: 2333-9705
ISSN Online: 2333-9721
www.scirp.net/journal/oalibj
E-mail: [email protected]

Citations

"Virological Profile of Patients Infected with HIV Starting Antiretroviral Treatment in Kinshasa"
written by Erick Ntambwe Kamangu, Ben Ilunga Bulanda, Berry Ikolango Bongenia, Huguette Tshweka Botomwito, Georges Lelo Mvumbi, Patrick De Mol, Dolores Vaira, Marie-Pierre Hayette, Richard Lunganza Kalala,
published by Open Access Library Journal, Vol.2 No.6, 2015

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Profile of People Living with Human Immunodeficiency Virus Initiating Treatment in the Dolutegravir Era in Kinshasa, Democratic Republic of Congo
	World Journal of …, 2023

[2]	Virological and Molecular Profile of People Living with the Human Immunodeficiency Virus Starting Dolutegravir Based Antiretroviral Treatment in Kinshasa …
	World Journal of …, 2023

[3]	Biological Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of the Congo
	World Journal of …, 2023

[4]	Compliance with First-Line AntiRetroViral Treatment (ART) for HIV Infection in the Era of Dolutegravir in Kinshasa, Democratic Republic of the Congo
	World Journal of …, 2023

[5]	Loss of People Living with HIV/AIDS in the Care Centers of Kinshasa, Democratic Republic of the Congo
	Open Access Library …, 2023

[6]	Virological and Molecular Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa
	World Journal of …, 2023

[7]	Prevalence of Anemia among People Living with HIV/AIDS Starting Antiretroviral Therapy in the Era of Dolutegravir in Kinshasa, Democratic Republic of …
	Open Access Library …, 2023

[8]	Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa
	Advances in Infectious …, 2023

[9]	Clinical and Anthropometric Evolution of People Living with Human Immunodeficiency Virus during 6 Months of Dolutegravir Treatment in Kinshasa …
	World Journal of …, 2023

[10]	Corona: Preventive Measures
	Asian Journal of Pharmaceutical …, 2023

[11]	Evolutionary Profile of Opportunistic Infections in People Living with Human Immunodeficiency Virus during Six Months of Dolutegravir Based Antiretroviral …
	World Journal of …, 2023

[12]	PROFIL EPIDEMIOLOGIQUE, CLINIQUE ET THERAPEUTIQUE DES PATIENTS INFECTES PAR LE VIH SOUS TRAITEMENT ANTIRETROVIRAL A …
	Mali Médical, 2023

[13]	Sociodemographic and Anthropometric Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of …
	Open Access Library …, 2022

[14]	Clinical Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of Congo
	Open Access Library …, 2022

[15]	Opportunistic Infections in People Living with Human Immunodeficiency Virus Initiating Antiretroviral Therapy in Kinshasa, Democratic Republic of Congo
	Austin J Infect …, 2022

[16]	Evaluation of Rational Use of Antiretrovirals before the Dolutegravir Transition in Kinshasa, Democratic Republic of Congo
	2021

[17]	Evaluation of the Oral Health of People Living with HIV in Kinshasa: Case of Saint Joseph Hospital (SJH)
	2020

[18]	Estimation of Clinical and Immunological Failure of First Line Antiretroviral Treatment in King Koti ART Centre, Hyderabad, Telangana
	2020

[19]	Clinical and Paraclinical Profile of People Living with Human Immunodeficiency Virus on Second Line Treatment in Kinshasa, Democratic Republic of Congo
	2019

[20]	Correlation between Mutations at the Beginning of Treatment and Virological Failure after 6 Months of Antiretroviral Treatment in People Living with the Human Immunodeficiency Virus in Kinshasa
	ARC Journal of AIDS, 2018

[21]	Sociodemographic and Anthropometric Profile of Positive HIV Patients in Early Traditional Treatment: Case of the Bonkoko Center
	2018

[22]	Evaluation of the Concordance of the Results of the Dried Plasma Spot and Liquid Plasma for the Determination of the Viral Load of the HIV in Kinshasa: Preliminary Study
	ARC Journal of AIDS, 2018

[23]	Molecular and Virological profile of Professional Sex Workers (PSW) and their Partners at the beginning of ARV Treatment at IST Matonge in Kinshasa
	2018

[24]	Estimation of Clinical, Immunological and Virological Failure of First Line Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo
	2018

[25]	Evaluation of the Effectiveness of the Cotrimoxazole and Antiretrovirals Association among Adult People Living with HIV: Case of Pilot Health Center and …
	2018

[26]	Correlation between Mutations at the Beginning of Treatment and Virological Failure after 6 Months of Antiretroviral Treatment in People Living with the …
	2018

[27]	Gender Difference in Early Treatment Patients for Human Immunodeficiency Virus Type 1 Infection in Kinshasa, Democratic Republic of Congo
	… Journal of HIV …, 2018

[28]	Involvement of the Genetic Diversity of HIV-1 in the Virological Treatment Failure of First Line Antiretroviral in Kinshasa
	2017

[29]	Human Immunodeficiency Vi-rus Type 1 and Type 2 Co-infection Rate in Kinshasa Patients. MJ HIV 1 (2): 009
	2016

[30]	Human Immunodeficiency Virus Type 1 and Type 2 Co-infection Rate in Kinshasa Patients
	Mathews Journal of HIV/AIDS, 2016

[31]	Correlation between Mutations at the Beginning of Treatment and Virological Failure after 6 Months of Antiretroviral Treatment in People Living with the Human …


[32]	Evaluation of the Concordance of the Results of the Dried Plasma Spot and Liquid Plasma for the Determination of the Viral Load of the HIV in Kinshasa …

[1]	Corona: Preventive Measures Asian Journal of Pharmaceutical Research, 2023 DOI:10.52711/2231-5691.2023.00021

[2]	Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa Advances in Infectious Diseases, 2023 DOI:10.4236/aid.2023.134054

[3]	Evolutionary Profile of Opportunistic Infections in People Living with Human Immunodeficiency Virus during Six Months of Dolutegravir Based Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo World Journal of AIDS, 2023 DOI:10.4236/wja.2023.132005

[4]	Clinical and Anthropometric Evolution of People Living with Human Immunodeficiency Virus during 6 Months of Dolutegravir Treatment in Kinshasa, Democratic Republic of Congo World Journal of AIDS, 2023 DOI:10.4236/wja.2023.132007

[5]	Virological and Molecular Profile of People Living with the Human Immunodeficiency Virus Starting Dolutegravir Based Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo World Journal of AIDS, 2023 DOI:10.4236/wja.2023.133008

[6]	Profile of People Living with Human Immunodeficiency Virus Initiating Treatment in the Dolutegravir Era in Kinshasa, Democratic Republic of Congo World Journal of AIDS, 2023 DOI:10.4236/wja.2023.133009

[7]	Compliance with First-Line AntiRetroViral Treatment (ART) for HIV Infection in the Era of Dolutegravir in Kinshasa, Democratic Republic of the Congo World Journal of AIDS, 2023 DOI:10.4236/wja.2023.131002

[8]	Biological Profile of People Living with Human Immunodeficiency Virus Starting Treatment in Kinshasa, Democratic Republic of the Congo World Journal of AIDS, 2023 DOI:10.4236/wja.2023.131001

[9]	Virological and Molecular Profile of People Living with HIV after 24 Weeks of Treatment with Dolutegravir in Kinshasa World Journal of AIDS, 2023 DOI:10.4236/wja.2023.134013

[10]	Involvement of the Genetic Diversity of HIV-1 in the Virological Treatment Failure of First Line Antiretroviral in Kinshasa World Journal of AIDS, 2017 DOI:10.4236/wja.2017.71003

	[email protected]
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Open Access Library Journal

Open Access Library Journal

Journals Menu

Guidelines & Policies

Home

About SCIRP

Service

Policies